{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:58:18Z","timestamp":1795028298085,"version":"4.10.2"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02285-y","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T05:11:01Z","timestamp":1742015461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiali","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renhua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erbao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,15]]},"reference":[{"issue":"1","key":"2285_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"7517","key":"2285_CR2","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/513S2a","volume":"513","author":"E Bender","year":"2014","unstructured":"Bender E. Epidemiology: the dominant malignancy. Nature. 2014;513(7517):S2\u20133.","journal-title":"Nature"},{"issue":"25","key":"2285_CR3","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","volume":"362","author":"M Maemondo","year":"2010","unstructured":"Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med. 2010;362(25):2380\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"2285_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1713137","volume":"378","author":"JC Soria","year":"2018","unstructured":"Soria JC, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee KH, Dechaphunkul A, Imamura F, Nogami N, Kurata T, et al. Osimertinib in untreated EGFR-Mutated advanced Non-Small-Cell lung Cancer. N Engl J Med. 2018;378(2):113\u201325.","journal-title":"N Engl J Med"},{"issue":"10","key":"2285_CR5","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1200\/JCO.22.02186","volume":"41","author":"RS Herbst","year":"2023","unstructured":"Herbst RS, Wu YL, John T, Grohe C, Majem M, Wang J, Kato T, Goldman JW, Laktionov K, Kim SW, et al. Adjuvant osimertinib for resected EGFR-Mutated stage IB-IIIA Non-Small-Cell lung cancer: updated results from the phase III randomized ADAURA trial. J Clin Oncol. 2023;41(10):1830\u201340.","journal-title":"J Clin Oncol"},{"issue":"suppl1","key":"2285_CR6","doi-asserted-by":"publisher","first-page":"i20","DOI":"10.1093\/annonc\/mdx704","volume":"29","author":"J Remon","year":"2018","unstructured":"Remon J, Steuer CE, Ramalingam SS, Felip E. Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients. Ann Oncol. 2018;29(suppl1):i20\u20137.","journal-title":"Ann Oncol"},{"issue":"12","key":"2285_CR7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun L, Zhang H, Gao P. Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell. 2022;13(12):877\u2013919.","journal-title":"Protein Cell"},{"issue":"1","key":"2285_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13059-019-1870-5","volume":"20","author":"Z Zhao","year":"2019","unstructured":"Zhao Z, Shilatifard A. Epigenetic modifications of histones in cancer. Genome Biol. 2019;20(1):245.","journal-title":"Genome Biol"},{"issue":"9","key":"2285_CR9","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/s41588-022-01173-1","volume":"54","author":"S Deng","year":"2022","unstructured":"Deng S, Zhang J, Su J, Zuo Z, Zeng L, Liu K, Zheng Y, Huang X, Bai R, Zhuang L, et al. RNA m(6)A regulates transcription via DNA demethylation and chromatin accessibility. Nat Genet. 2022;54(9):1427\u201337.","journal-title":"Nat Genet"},{"key":"2285_CR10","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.semcancer.2020.11.008","volume":"83","author":"H Fatma","year":"2022","unstructured":"Fatma H, Maurya SK, Siddique HR. Epigenetic modifications of c-MYC: role in cancer cell reprogramming, progression and chemoresistance. Semin Cancer Biol. 2022;83:166\u201376.","journal-title":"Semin Cancer Biol"},{"issue":"13","key":"2285_CR11","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-22-3059","volume":"83","author":"Z Lin","year":"2023","unstructured":"Lin Z, Li J, Zhang J, Feng W, Lu J, Ma X, Ding W, Ouyang S, Lu J, Yue P, et al. Metabolic reprogramming driven by IGF2BP3 promotes acquired resistance to EGFR inhibitors in Non-Small cell lung Cancer. Cancer Res. 2023;83(13):2187\u2013207.","journal-title":"Cancer Res"},{"issue":"21","key":"2285_CR12","doi-asserted-by":"publisher","first-page":"e2114324119","DOI":"10.1073\/pnas.2114324119","volume":"119","author":"M Baratchian","year":"2022","unstructured":"Baratchian M, Tiwari R, Khalighi S, Chakravarthy A, Yuan W, Berk M, Li J, Guerinot A, de Bono J, Makarov V, et al. H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer. Proc Natl Acad Sci U S A. 2022;119(21):e2114324119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2285_CR13","doi-asserted-by":"publisher","first-page":"215971","DOI":"10.1016\/j.canlet.2022.215971","volume":"553","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Qiu JG, Jia XY, Ke Y, Zhang MK, Stieg D, Liu WJ, Liu LZ, Wang L, Jiang BH. METTL3-mediated N6-methyladenosine modification and HDAC5\/YY1 promote IFFO1 downregulation in tumor development and chemo-resistance. Cancer Lett. 2023;553:215971.","journal-title":"Cancer Lett"},{"issue":"6","key":"2285_CR14","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1093\/nar\/gkw1247","volume":"45","author":"E Zhang","year":"2017","unstructured":"Zhang E, Han L, Yin D, He X, Hong L, Si X, Qiu M, Xu T, De W, Xu L, et al. H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma. Nucleic Acids Res. 2017;45(6):3086\u2013101.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2285_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13059-018-1523-0","volume":"19","author":"E Zhang","year":"2018","unstructured":"Zhang E, He X, Zhang C, Su J, Lu X, Si X, Chen J, Yin D, Han L, De W. A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1. Genome Biol. 2018;19(1):154.","journal-title":"Genome Biol"},{"issue":"7","key":"2285_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/cac2.12325","volume":"42","author":"C Zhang","year":"2022","unstructured":"Zhang C, Sun Q, Zhang X, Qin N, Pu Z, Gu Y, Yan C, Zhu M, Dai J, Wang C, et al. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma. Cancer Commun (Lond). 2022;42(7):609\u201326.","journal-title":"Cancer Commun (Lond)"},{"issue":"5","key":"2285_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41419-023-05840-x","volume":"14","author":"J Dai","year":"2023","unstructured":"Dai J, Qu T, Yin D, Cui Y, Zhang C, Zhang E, Guo R. LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer. Cell Death Dis. 2023;14(5):312.","journal-title":"Cell Death Dis"},{"issue":"23","key":"2285_CR18","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1158\/0008-5472.CAN-22-1289","volume":"82","author":"Q Zhu","year":"2022","unstructured":"Zhu Q, Zhang C, Qu T, Lu X, He X, Li W, Yin D, Han L, Guo R, Zhang E. MNX1-AS1 promotes phase separation of IGF2BP1 to drive c-Myc-Mediated Cell-Cycle progression and proliferation in lung Cancer. Cancer Res. 2022;82(23):4340\u201358.","journal-title":"Cancer Res"},{"issue":"4","key":"2285_CR19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides T. Chromatin modifications and their function. Cell. 2007;128(4):693\u2013705.","journal-title":"Cell"},{"issue":"10","key":"2285_CR20","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/nbt.1685","volume":"28","author":"A Portela","year":"2010","unstructured":"Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 2010;28(10):1057\u201368.","journal-title":"Nat Biotechnol"},{"issue":"7779","key":"2285_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W, Kim S, Lee S, Perez-Neut M, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.","journal-title":"Nature"},{"issue":"1","key":"2285_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/gutjnl-2022-328408","volume":"73","author":"Z Wang","year":"2023","unstructured":"Wang Z, Wang Q, Chen C, Zhao X, Wang H, Xu L, Fu Y, Huang G, Li M, Xu J, et al. NNMT enriches for AQP5(+) cancer stem cells to drive malignant progression in early gastric cardia adenocarcinoma. Gut. 2023;73(1):63\u201377.","journal-title":"Gut"},{"issue":"1","key":"2285_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13058-019-1150-z","volume":"21","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zeng J, Wu W, Xie S, Yu H, Li G, Zhu T, Li F, Lu J, Wang GY, et al. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization. Breast Cancer Res. 2019;21(1):64.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"2285_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"issue":"1","key":"2285_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12943-022-01547-3","volume":"21","author":"Z Pan","year":"2022","unstructured":"Pan Z, Wang K, Wang X, Jia Z, Yang Y, Duan Y, Huang L, Wu ZX, Zhang JY, Ding X. Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR\/Src\/Erk\/SP1 signaling-mediated erralpha re-expression. Mol Cancer. 2022;21(1):77.","journal-title":"Mol Cancer"},{"issue":"3","key":"2285_CR26","doi-asserted-by":"publisher","first-page":"e2001951","DOI":"10.1371\/journal.pbio.2001951","volume":"15","author":"S Di Biase","year":"2017","unstructured":"Di Biase S, Shim HS, Kim KH, Vinciguerra M, Rappa F, Wei M, Brandhorst S, Cappello F, Mirzaei H, Lee C, et al. Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy. PLoS Biol. 2017;15(3):e2001951.","journal-title":"PLoS Biol"},{"issue":"22","key":"2285_CR27","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1182\/blood.2023020142","volume":"142","author":"Y Liu","year":"2023","unstructured":"Liu Y, Kimpara S, Hoang NM, Daenthanasanmak A, Li Y, Lu L, Ngo VN, Bates PD, Song L, Gao X, et al. EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphoma. Blood. 2023;142(22):1879\u201394.","journal-title":"Blood"},{"issue":"1","key":"2285_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41421-023-00521-7","volume":"9","author":"J Yu","year":"2023","unstructured":"Yu J, Zhuang A, Gu X, Hua Y, Yang L, Ge S, Ruan J, Chai P, Jia R, Fan X. Nuclear PD-L1 promotes EGR1-mediated angiogenesis and accelerates tumorigenesis. Cell Discov. 2023;9(1):33.","journal-title":"Cell Discov"},{"issue":"7758","key":"2285_CR29","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41586-019-1173-8","volume":"569","author":"MA Eckert","year":"2019","unstructured":"Eckert MA, Coscia F, Chryplewicz A, Chang JW, Hernandez KM, Pan S, Tienda SM, Nahotko DA, Li G, Blazenovic I, et al. Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. Nature. 2019;569(7758):723\u20138.","journal-title":"Nature"},{"issue":"1","key":"2285_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41389-022-00415-5","volume":"11","author":"S Lu","year":"2022","unstructured":"Lu S, Ke S, Wang C, Xu Y, Li Z, Song K, Bai M, Zhou M, Yu H, Yin B, et al. NNMT promotes the progression of intrahepatic cholangiocarcinoma by regulating aerobic Glycolysis via the EGFR-STAT3 axis. Oncogenesis. 2022;11(1):39.","journal-title":"Oncogenesis"},{"issue":"5","key":"2285_CR31","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.3892\/mmr.2016.5815","volume":"14","author":"AS Guo","year":"2016","unstructured":"Guo AS, Huang YQ, Ma XD, Lin RS. Mechanism of G9a inhibitor BIX\u201301294 acting on U251 glioma cells. Mol Med Rep. 2016;14(5):4613\u201321.","journal-title":"Mol Med Rep"},{"issue":"6","key":"2285_CR32","doi-asserted-by":"publisher","first-page":"102017","DOI":"10.1016\/j.jbc.2022.102017","volume":"298","author":"JJ Wang","year":"2022","unstructured":"Wang JJ, Wang X, Xian YE, Chen ZQ, Sun YP, Fu YW, Wu ZK, Li PX, Zhou ES, Yang ZT. The JMJD3 histone demethylase inhibitor GSK-J1 ameliorates lipopolysaccharide-induced inflammation in a mastitis model. J Biol Chem. 2022;298(6):102017.","journal-title":"J Biol Chem"},{"issue":"9","key":"2285_CR33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41419-023-06142-y","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yan H, Yan L, Wang X, Che X, Hou K, Yang Y, Li X, Li Y, Zhang Y, et al. Hypoxia-induced ALDH3A1 promotes the proliferation of non-small-cell lung cancer by regulating energy metabolism reprogramming. Cell Death Dis. 2023;14(9):617.","journal-title":"Cell Death Dis"},{"issue":"2","key":"2285_CR34","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1021\/jm401508p","volume":"57","author":"B Parajuli","year":"2014","unstructured":"Parajuli B, Fishel ML, Hurley TD. Selective ALDH3A1 Inhibition by benzimidazole analogues increase Mafosfamide sensitivity in cancer cells. J Med Chem. 2014;57(2):449\u201361.","journal-title":"J Med Chem"},{"issue":"1","key":"2285_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13059-023-02931-y","volume":"24","author":"X Wang","year":"2023","unstructured":"Wang X, Fan W, Li N, Ma Y, Yao M, Wang G, He S, Li W, Tan J, Lu Q, et al. YY1 lactylation in microglia promotes angiogenesis through transcription activation-mediated upregulation of FGF2. Genome Biol. 2023;24(1):87.","journal-title":"Genome Biol"},{"issue":"1","key":"2285_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","volume":"22","author":"J Yu","year":"2021","unstructured":"Yu J, Chai P, Xie M, Ge S, Ruan J, Fan X, Jia R. Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 2021;22(1):85.","journal-title":"Genome Biol"},{"issue":"9","key":"2285_CR37","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong J, He J, Zhu J, Pan J, Liao W, Ye H, Wang H, Song Y, Du Y, Cui B, et al. Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell. 2022;82(9):1660\u2013e16771610.","journal-title":"Mol Cell"},{"issue":"23","key":"2285_CR38","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1161\/CIRCULATIONAHA.121.057599","volume":"145","author":"R Chakraborty","year":"2022","unstructured":"Chakraborty R, Ostriker AC, Xie Y, Dave JM, Gamez-Mendez A, Chatterjee P, Abu Y, Valentine J, Lezon-Geyda K, Greif DM, et al. Histone acetyltransferases p300 and CBP coordinate distinct chromatin remodeling programs in vascular smooth muscle plasticity. Circulation. 2022;145(23):1720\u201337.","journal-title":"Circulation"},{"issue":"1","key":"2285_CR39","doi-asserted-by":"publisher","first-page":"e2202642","DOI":"10.1002\/advs.202202642","volume":"10","author":"C Wu","year":"2022","unstructured":"Wu C, Liu Y, Liu W, Zou T, Lu S, Zhu C, He L, Chen J, Fang L, Zou L, et al. NNMT-DNMT1 Axis is essential for maintaining Cancer cell sensitivity to oxidative phosphorylation Inhibition. Adv Sci (Weinh). 2022;10(1):e2202642.","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"2285_CR40","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/neuonc\/now049","volume":"18","author":"PJ Cook","year":"2016","unstructured":"Cook PJ, Thomas R, Kingsley PJ, Shimizu F, Montrose DC, Marnett LJ, Tabar VS, Dannenberg AJ, Benezra R. Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma. Neuro Oncol. 2016;18(10):1379\u201389.","journal-title":"Neuro Oncol"},{"issue":"1","key":"2285_CR41","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"Li W, Zhou C, Yu L, Hou Z, Liu H, Kong L, Xu Y, He J, Lan J, Ou Q, et al. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 2024;20(1):114\u201330.","journal-title":"Autophagy"},{"issue":"1","key":"2285_CR42","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41420-022-00966-x","volume":"8","author":"J Wang","year":"2022","unstructured":"Wang J, Liu X, Huang Y, Li P, Yang M, Zeng S, Chen D, Wang Q, Liu H, Luo K, et al. Targeting nicotinamide N-methyltransferase overcomes resistance to EGFR-TKI in non-small cell lung cancer cells. Cell Death Discov. 2022;8(1):170.","journal-title":"Cell Death Discov"},{"issue":"8","key":"2285_CR43","doi-asserted-by":"publisher","first-page":"112961","DOI":"10.1016\/j.celrep.2023.112961","volume":"42","author":"H Yao","year":"2023","unstructured":"Yao H, Chen X, Wang T, Kashif M, Qiao X, Tuksammel E, Larsson LG, Okret S, Sayin VI, Qian H, et al. A MYC-controlled redox switch protects B lymphoma cells from EGR1-dependent apoptosis. Cell Rep. 2023;42(8):112961.","journal-title":"Cell Rep"},{"key":"2285_CR44","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.omtn.2018.03.011","volume":"11","author":"DH Bach","year":"2018","unstructured":"Bach DH, Kim D, Bae SY, Kim WK, Hong JY, Lee HJ, Rajasekaran N, Kwon S, Fan Y, Luu TT, et al. Targeting nicotinamide N-Methyltransferase and miR-449a in EGFR-TKI-Resistant Non-Small-Cell lung Cancer cells. Mol Ther Nucleic Acids. 2018;11:455\u201367.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"2285_CR45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13046-024-03161-1","volume":"43","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zhang G, Xiao M, Cui S, Jin C, Yang J, Wu S, Lu X. Two-polarized roles of transcription factor FOSB in lung cancer progression and prognosis: dependent on p53 status. J Exp Clin Cancer Res. 2024;43(1):237.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2285_CR46","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1186\/s12967-023-04703-5","volume":"21","author":"S Wang","year":"2023","unstructured":"Wang S, Cheng Z, Cui Y, Xu S, Luan Q, Jing S, Du B, Li X, Li Y. PTPRH promotes the progression of non-small cell lung cancer via Glycolysis mediated by the PI3K\/AKT\/mTOR signaling pathway. J Transl Med. 2023;21(1):819.","journal-title":"J Transl Med"},{"key":"2285_CR47","doi-asserted-by":"publisher","first-page":"111415","DOI":"10.1016\/j.cellsig.2024.111415","volume":"124","author":"Y Liu","year":"2024","unstructured":"Liu Y, Qing B, Ke W, Wang M. MEK inhibitor Trametinib combined with PI3K\/mTOR inhibitor BEZ-235 as an effective strategy against NSCLC through impairment of glucose metabolism. Cell Signal. 2024;124:111415.","journal-title":"Cell Signal"},{"key":"2285_CR48","doi-asserted-by":"crossref","unstructured":"Zong Z, Xie F, Wang S, Wu X, Zhang Z, Yang B, Zhou F. Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell 2024.","DOI":"10.1016\/j.cell.2024.04.002"},{"key":"2285_CR49","doi-asserted-by":"publisher","first-page":"216824","DOI":"10.1016\/j.canlet.2024.216824","volume":"589","author":"T Yu","year":"2024","unstructured":"Yu T, Liu Z, Tao Q, Xu X, Li X, Li Y, Chen M, Liu R, Chen D, Wu M, et al. Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming. Cancer Lett. 2024;589:216824.","journal-title":"Cancer Lett"},{"issue":"5","key":"2285_CR50","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nchembio.1204","volume":"9","author":"OA Ulanovskaya","year":"2013","unstructured":"Ulanovskaya OA, Zuhl AM, Cravatt BF. NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nat Chem Biol. 2013;9(5):300\u20136.","journal-title":"Nat Chem Biol"},{"key":"2285_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.abb.2014.08.017","volume":"564","author":"X Xie","year":"2014","unstructured":"Xie X, Yu H, Wang Y, Zhou Y, Li G, Ruan Z, Li F, Wang X, Liu H, Zhang J. Nicotinamide N-methyltransferase enhances the capacity of tumorigenesis associated with the promotion of cell cycle progression in human colorectal cancer cells. Arch Biochem Biophys. 2014;564:52\u201366.","journal-title":"Arch Biochem Biophys"},{"key":"2285_CR52","doi-asserted-by":"crossref","unstructured":"Duong HQ, You KS, Oh S, Kwak SJ, Seong YS. Silencing of NRF2 reduces the expression of ALDH1A1 and ALDH3A1 and sensitizes to 5-FU in pancreatic Cancer cells. Antioxid (Basel) 2017, 6(3).","DOI":"10.3390\/antiox6030052"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02285-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02285-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02285-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T16:44:59Z","timestamp":1742057099000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02285-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2285"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02285-y","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,15]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee on Human Research of the First Affiliated Hospital of Nanjing Medical University, and it was performed in compliance with the Helsinki Declaration. All patients have given written informed consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}